Nirsevimab 50MG PFS 5S
Ended Awarded
- Contract number
- SPE2DX25FPHGH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,560
Award facts
- Contract value 100% obligated
- $3,559.64 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,559.64 for Nirsevimab 50mg prefilled syringes (5-pack) by the Defense Logistics Agency's Medical Supply Chain division on September 26, 2025. This delivery order, which serves as the ultimate completion date, was issued without a set-aside designation, leveraging the company's competitive status within federal procurement markets. The award represents a specific pharmaceutical product draw-down from DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion single-award vehicle valid through November 2026 that enables the agency to procure comprehensive pharmaceutical supplies for military health facilities worldwide.
The delivery order will be fulfilled at the contractor's location in Park Ridge, Illinois, and reflects the company's established role as a critical supplier in the federal pharmaceutical supply chain. DMS Pharmaceutical Group's portfolio encompasses branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables across diverse therapeutic categories. Nirsevimab, a monoclonal antibody used for respiratory syncytial virus prevention, aligns with the Defense Logistics Agency's requirement to maintain robust pharmaceutical inventories supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DX25FPHGH?
SPE2DX25FPHGH was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 26, 2025.
How much is contract SPE2DX25FPHGH worth?
The government has obligated $3,560 on SPE2DX25FPHGH.
Is contract SPE2DX25FPHGH an order under another contract?
Yes. SPE2DX25FPHGH is a delivery order under SPE2DX15D9762, an indefinite delivery contract.
Was contract SPE2DX25FPHGH competed?
The extent of competition for SPE2DX25FPHGH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award